title: Treating PIK3CA and EGFR overexpressing breast cancers with lithium citrate.
authors.affiliation: Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
authors.forename: Toni M
authors.initials: TM
authors.lastname: Brand
authors.forename: Deric L
authors.initials: DL
authors.lastname: Wheeler
mesh_terms: D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics; D002951:Citrates / Q000627:therapeutic use*; D058534:Class I Phosphatidylinositol 3-Kinases; D066246:ErbB Receptors / Q000235:genetics* / Q000378:metabolism; D005260:Female; D006801:Humans; D019869:Phosphatidylinositol 3-Kinases / Q000235:genetics* / Q000378:metabolism; D011379:Prognosis
chemical_list: D002951:Citrates; C070669:lithium citrate; D019869:Phosphatidylinositol 3-Kinases; D058534:Class I Phosphatidylinositol 3-Kinases; C484760:PIK3CA protein, human; D066246:ErbB Receptors